Patients
Trials
Expanded Access
Pipeline
Zanidatamab
Zanidatamab Zovodotin
Preclinical & Advanced Discovery
Partnerships
Publications
Partners
Technology
Azymetric™
ZymeLink™
EFECT™
ProTECT™
Science
Careers
Apply
Perks & Benefits
Corporate Gallery
About
Leadership
Board of Directors
News
Investors & Media
News
Zymeworks Provides Corporate Update And Reports Second Quarter 2022 Financial Results
Aug 04, 2022
Back